Change of Safety Interval from Hyperviscosity Problem in COVID-19 Vaccine Recipient with Underlying Diabetic Problem.
Change of Safety Interval from Hyperviscosity Problem in COVID-19 Vaccine Recipient with Underlying Diabetic Problem.
复制标题
DOI：
10.4103/ijem.ijem_308_21
复制
发表时间：
2021-05
影响因子：
--
通讯作者：
Wiwanitkit V
中科院分区：
文献类型：
--
作者：
Sookaromdee P;Wiwanitkit V
""